Patrick Blin
About
In The Last Decade
Patrick Blin
143 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Cardiology and Cardiovascular Medicine 662
- Epidemiology 580
- Pharmacology 408
- Surgery 392
- Endocrinology, Diabetes and Metabolism 308
Countries citing papers authored by Patrick Blin
This map shows the geographic impact of Patrick Blin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Blin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Blin more than expected).
Fields of papers citing papers by Patrick Blin
This network shows the impact of papers produced by Patrick Blin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Blin. The network helps show where Patrick Blin may publish in the future.
Co-authorship network of co-authors of Patrick Blin
This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Blin. A scholar is included among the top collaborators of Patrick Blin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Blin. Patrick Blin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 23 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | Abstract 14523: Two-Year Benefit-Risk of Standard and Reduced Doses of Rivaroxaban versus Vitamin-K Antagonists in Non-Valvular Atrial Fibrillation: A Cohort Study in the French Nationwide Claims Database | 1 |
| 11 | Abstract 20559: Effectiveness and Safety of Rivaroxaban 15 mg Compared With Vitamin K Antagonists in Very Elderly Patients With Atrial Fibrillation, a Matched Cohort Study in the French Nationwide Claims Database SNIIRAM | 1 |
| 12 | Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study | 1 |
| 13 | 17 | |
| 14 | 4 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 19 | |
| 18 | 258 | |
| 19 | [Impact of an information campaign on cardiovascular risk factors. 5-year results at the study town Epernon]. | 5 |
| 20 | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.